venBio Select Advisor »

Hemab Therapeutics Holdings shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Hemab Therapeutics Holdings shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Hemab Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Hemab Therapeutics Holdings held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hemab Therapeutics Holdings by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2026-06-30 $71M 1.9M 36.73

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Ascendis Pharma Ordinary Shares (ASND)
Krystal Biotech Common (KRYS)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Revolution Medicines Common (RVMD)
Cytokinetics Common (CYTK)
Celcuity Common (CELC)
Structure Therapeutics Sponsored Ads (GPCR)
Xenon Pharmaceuticals Common (XENE)
Definium Therapeutics Common (DFTX)
Uniqure Nv Common (QURE)
Vera Therapeutics Common (VERA)

View all positions for venBio Select Advisor

Top funds holding Hemab Therapeutics Holdings

RA Capital Management
Novo A/S
FMR
Capital Research and Management Company - Division 3
venBio Select Advisor
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Vanguard Capital Management
Driehaus Capital Management
Rock Springs Capital Management
Bellevue Group
Citadel Advisors
Deerfield Management Company
ExodusPoint Capital Management
Geode Capital Management

View all funds holding Hemab Therapeutics Holdings